Global respiratory monitoring device market is expected to grow at the CAGR of 10.29% and to contribute $3.67 billion by 2022. Respiratory diseases are serious health concern owing to rapidly growing number of smokers worldwide. Governments are now taking initiatives, implementing various health schemes to decrease the death rates caused by respiratory disease and disorders. Respiratory diseases are the medical conditions that affect the structure and organs (respiratory system) related with respiration or breathing. Increasing respiratory diseases such as chronic obstructive pulmonary diseases, asthma, and lung cancer has boosted the growth of the respiratory monitoring devices market. In addition to it, there has been a paradigm shift from hospital care to home health care. This is because of high hospital expenditure, decline in medical compensation due to cost containment issues, and rise in the geriatric population. These factors are anticipated to contribute to the growth of the respiratory monitoring devices market.
Respiratory monitoring devices are the collection of medical devices which focus on the control, management, diagnostic evaluation and intensive care of patients with cardiopulmonary systems abnormality. A degenerative lung disease, chronic obstructive pulmonary diseases (COPD), and emphysema generally require these respiratory monitoring devices. The market for these devices is expected to show huge growth as one of the major causes for the deaths worldwide is COPD. COPD is recognized as the fifth leading cause for deaths worldwide by 2022. Some of the driving factors for the global respiratory monitoring devices market are rise in the number of chronic pulmonary obstructive diseased patients, changing life style and environment like increasing pollution level and smokers, and rising geriatric population. However, lack of awareness in some regions, and harmful effects of respiratory devices on neonates are the restraining factors for the market growth. Also the excise tax on devices is expected to impact the market growth.
The pulse oximeters segment dominated the global respiratory monitoring devices market in the year 2015. Factors such as high precision, rapid, and effective results produced by the device fuels the growth of the segment. The pulse oximeters segment is also anticipated to register the fastest growth in the forecast period due to better diagnostic result in a shorter span of time as compared to other monitoring devices. Moreover, rising number of hospital admissions due to increasing respiratory disorders amongst the global population contributs to the growth of the hospitals end-user segment.
The global respiratory monitoring devices market is segmented on the basis of products and end users. By product, respiratory monitoring devices market is divided as spirometer, peak flow meter, and pulse oximeter and capnographs devices. On the basis of end users, the respiratory monitoring devices market is segmented as home monitoring and hospitals. In the end user segment, the hospital’s segment is expected to have the largest share of nearly 65% of the total market. But still home monitoring segment is anticipated to have fastest growth in the coming future, due to increase in development of lightweight and compact respiratory monitoring devices which are easier to operate.
On regional basis, the respiratory monitoring devices market is segmented into Europe, North America, Asia-Pacific, Middle East & Africa and Latin America. Health monitoring systems are developing in each and every region rapidly. Moreover, large investment in health monitoring segment are the important factors which are responsible for the largest share of the Europe and North America in global respiratory monitoring devices market. Asia-Pacific region is expected to grow with highest CAGR, due to the increase in number of respiratory patients, increasing per capita income and rapidly developing health monitoring infrastructure in developing countries of this region. In addition, the major players of the industry are located in North America, so the rate of innovation and up gradation is higher in this region as compared to the other regions. However, APAC is anticipated to be the fastest growing market. It is anticipated to grow at a CAGR of 12.62% during the forecast period of 2016-2022. In APAC, countries such as China, India and Korea are creating immense growth opportunities for global respiratory care devices market. Major factors driving the market in APAC region are, increasing healthcare expenditure, increasing aging population and rising opportunities in various un-penetrated markets and increasing investments etc.
Major players in respiratory monitoring devices market are, CareFusion Corporation, Smiths Medical, ResMed, Inc., Masimo Corporation. COSMED, GE Healthcare, MGC Diagnostic Corporation, ndd Medical Technologies, Inc., etc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market, like, one recent acquisition (June 2016) done by GE Healthcare, acquisition of Biosafe Group. Biosafe Group SA, a supplier of integrated cell bioprocessing systems for the increasingly growing cell therapy and regenerative medicine industry. The acquisition expands GE Healthcare’s end-to-end ecosystem of products, solutions and services for cell therapy customers, and hence expands GE’s technology reach to a number of new cell and therapy types.